Lingaraja Jena

528 total citations
38 papers, 373 citations indexed

About

Lingaraja Jena is a scholar working on Molecular Biology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Lingaraja Jena has authored 38 papers receiving a total of 373 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 14 papers in Infectious Diseases and 14 papers in Epidemiology. Recurrent topics in Lingaraja Jena's work include Tuberculosis Research and Epidemiology (12 papers), Computational Drug Discovery Methods (12 papers) and vaccines and immunoinformatics approaches (10 papers). Lingaraja Jena is often cited by papers focused on Tuberculosis Research and Epidemiology (12 papers), Computational Drug Discovery Methods (12 papers) and vaccines and immunoinformatics approaches (10 papers). Lingaraja Jena collaborates with scholars based in India and United States. Lingaraja Jena's co-authors include Satish Kumar, Maheswata Sahoo, B. C. Harinath, Ashok K. Varma, Satish Kumar, Ritu Gupta, Manorama Patri, Gurvinder Kaur, Lata Rani and Anubha Gupta and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Biomolecular Structure and Dynamics.

In The Last Decade

Lingaraja Jena

34 papers receiving 355 citations

Peers

Countries citing papers authored by Lingaraja Jena

Since Specialization

Citations

This map shows the geographic impact of Lingaraja Jena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingaraja Jena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingaraja Jena more than expected).

Fields of papers citing papers by Lingaraja Jena

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingaraja Jena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingaraja Jena. The network helps show where Lingaraja Jena may publish in the future.

Co-authorship network of co-authors of Lingaraja Jena

This figure shows the co-authorship network connecting the top 25 collaborators of Lingaraja Jena. A scholar is included among the top collaborators of Lingaraja Jena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingaraja Jena. Lingaraja Jena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Correlation of changes in subclonal architecture with progression in the MMRF CoMMpass study 2022 ·Translational Oncology ·Gurvinder Kaur, Lingaraja Jena, Ritu Gupta, (unknown), Anubha Gupta, K. Sriram	5
2	Characterizing the mutational landscape of MM and its precursor MGUS. 2022 ·PubMed ·(unknown), Anubha Gupta, Lingaraja Jena, (unknown), Gurvinder Kaur, Ritu Gupta	4
3	Genome-wide identification of potential biomarkers in multiple myeloma using meta-analysis of mRNA and miRNA expression data 2021 ·Scientific Reports ·Amit Katiyar, Gurvinder Kaur, Lata Rani, Lingaraja Jena, Harpreet Singh, Lalit Kumar, Atul Sharma, Punit Kaur, Ritu Gupta	17
4	In silico discovery and evaluation of phytochemicals binding mechanism against human catechol-O-methyltransferase as a putative bioenhancer of L-DOPA therapy in Parkinson disease 2021 ·Genomics & Informatics ·(unknown), Lingaraja Jena, (unknown), (unknown), Manorama Patri	4
5	An In silico approach to identify potential inhibitors against multiple drug targets of Mycobacterium tuberculosis 2019 ·International Journal of Mycobacteriology ·Satish Kumar, (unknown), Lingaraja Jena	10
6	Identification of potential inhibitors for mycobacterial uridine diphosphogalactofuranose-galactopyranose mutase enzyme: A novel drug target through in silico approach 2018 ·International Journal of Mycobacteriology ·(unknown), (unknown), Lingaraja Jena, (unknown)	3
7	Discovery of T-cell Driven Subunit Vaccines from Zika Virus Genome: An Immunoinformatics Approach 2017 ·Interdisciplinary Sciences Computational Life Sciences ·Dibyabhaba Pradhan, Monika Yadav, (unknown), (unknown), Lingaraja Jena, Arun K. Jain	12
8	Inhibition of mycobacterial CYP125 enzyme by sesamin and β-sitosterol: An in silico and in vitro study 2017 ·Biomedical and Biotechnology Research Journal (BBRJ) ·(unknown), (unknown), Sarika M. Kamble, (unknown), Lingaraja Jena, (unknown)	6
9	Identification of Suitable Natural Inhibitor against Influenza A (H1N1) Neuraminidase Protein by Molecular Docking 2016 ·Genomics & Informatics ·Maheswata Sahoo, Lingaraja Jena, (unknown), Satish Kumar	48
10	Phylogenetic Analysis of H1N1 Proteins for Understanding Its Allocation 2015 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Lingaraja Jena, Satish Kumar	1
11	Virtual screening for potential inhibitors of high-risk human papillomavirus 16 E6 protein 2015 ·Interdisciplinary Sciences Computational Life Sciences ·Satish Kumar, Lingaraja Jena, (unknown), (unknown), Ashok K. Varma	2
12	Virtual Screening for Potential Inhibitors of High-Risk Human Papillomavirus 16 E6 Protein 2015 ·Interdisciplinary Sciences Computational Life Sciences ·Satish Kumar, Lingaraja Jena, (unknown), (unknown), Ashok K. Varma	17
13	Study of mechanism of interaction of truncated isoniazid–nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach 2015 ·International Journal of Mycobacteriology ·Lingaraja Jena, (unknown), (unknown), Satish Kumar, B. C. Harinath	12
14	Computational approach to understanding the mechanism of action of isoniazid, an anti-TB drug 2014 ·International Journal of Mycobacteriology ·Lingaraja Jena, (unknown), (unknown), Satish Kumar, B. C. Harinath	46
15	Exploiting nanoparticle for targeted apoptosis as therapeutic modality against filarial parasite: A plausible premise 2014 ·Kalyan Goswami, (unknown), (unknown), Lingaraja Jena, (unknown)	2
16	Effect of single amino acid mutations on function of Mycobacterium tuberculosis H37RV and H37RA by computational approaches. 2014 ·PubMed ·Lingaraja Jena, (unknown), (unknown), B. C. Harinath	1
17	Comparative proteomic analysis of Mycobacterium tuberculosis strain H37Rv versus H37Ra 2013 ·SHILAP Revista de lepidopterología ·Lingaraja Jena, (unknown), Satish Kumar, B. C. Harinath	14
18	In silico Structural Prediction of E6 and E7 Proteins of Human Papillomavirus Strains by Comparative Modeling 2012 ·SHILAP Revista de lepidopterología ·Satish Kumar, Lingaraja Jena, (unknown), (unknown)	0
19	MycoProtease-DB: Useful resource for Mycobacterium tuberculosis complex and nontuberculous mycobacterial proteases 2012 ·Bioinformation ·Lingaraja Jena, (unknown), B. C. Harinath	1
20	MTB-PCDB: Mycobacterium tuberculosis proteome comparison database 2011 ·Bioinformation ·Lingaraja Jena, (unknown), (unknown), B. C. Harinath	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact